Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device

Percutaneous closure of patent foramen ovale (PFO) is routinely performed with nonbiological devices, characterized by a persistent low‐grade inflammatory response. We report our experience about PFO closure with a bioabsorbable device, BioSTAR® (NMT Inc, USA).

[1]  P. Puri,et al.  Late presentation of CardioSEAL PFO closure device fracture and thrombus formation three years after device implantation. , 2008, The Journal of invasive cardiology.

[2]  W. Hillis,et al.  BioSTAR Evaluation STudy (BEST): A Prospective, Multicenter, Phase I Clinical Trial to Evaluate the Feasibility, Efficacy, and Safety of the BioSTAR Bioabsorbable Septal Repair Implant for the Closure of Atrial-Level Shunts , 2006, Circulation.

[3]  C. White,et al.  Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale. , 2006, The Journal of invasive cardiology.

[4]  P. Wohlsein,et al.  Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. , 2006, Journal of the American College of Cardiology.

[5]  J. Tobis,et al.  Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. , 2006, Journal of the American College of Cardiology.

[6]  V. Chair,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Circulation.

[7]  J. Tobis,et al.  Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: A case report , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  M. Desnos,et al.  Obstructive sleep apnoea and patent foramen ovale: successful treatment of symptoms by percutaneous foramen ovale closure. , 2005, Journal of interventional cardiology.

[9]  W. Budts,et al.  Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome , 2005, Acta cardiologica.

[10]  H. Herrmann,et al.  Transcatheter device closure of interatrial septal defects in patients with hypoxia. , 2005, Journal of interventional cardiology.

[11]  A. Delabays,et al.  Percutaneous closure of patent foramen ovale: head-to-head comparison of two different devices , 2005 .

[12]  J. Cheatham,et al.  Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  D. Hagler,et al.  Thrombosis after septal closure device placement: A review of the current literature , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  D. Turner,et al.  Nickel allergy and the amplatzer septal occluder. , 2004, The Journal of invasive cardiology.

[15]  M. Schwerzmann,et al.  Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. , 2004, Journal of the American College of Cardiology.

[16]  J. Gold,et al.  Late cardiac perforation following transcatheter atrial septal defect closure. , 2004, The Annals of thoracic surgery.

[17]  H. Sievert,et al.  Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. , 2004, Journal of the American College of Cardiology.

[18]  P. Wohlsein,et al.  A new biological matrix for septal occlusion. , 2003, Journal of interventional cardiology.

[19]  H. Rupprecht,et al.  Nickel release after implantation of the Amplatzer occluder. , 2003, American heart journal.

[20]  A. Raviele,et al.  Single-center experience with the HELEX septal occluder for closure of atrial septal defects in children. , 2003, Journal of interventional cardiology.

[21]  D. Fassbender,et al.  Systemic allergic reaction to the percutaneous patent foramen ovale occluder. , 2003, The Journal of thoracic and cardiovascular surgery.

[22]  F. Buonanno,et al.  Percutaneous Transcatheter Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism , 2002, Circulation.

[23]  P. Pullicino,et al.  "Economy class" stroke syndrome? , 2002, Neurology.

[24]  P. Rehak,et al.  Transesophageal Echocardiography for Quantifying Size of Patent Foramen Ovale in Patients With Cryptogenic Cerebrovascular Events , 2002, Stroke.

[25]  J. Coste,et al.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. , 2001, The New England journal of medicine.

[26]  M. Grandis,et al.  Very High Prevalence of Right-to-Left Shunt on Transcranial Doppler in an Italian Family with Cerebral Autosomal Dominant Angiopathy with Subcortical Infarcts and Leukoencephalopathy , 2001, European Neurology.

[27]  G. Anzola,et al.  Transcranial Doppler in the diagnosis of cardiac patent foramen ovale , 2001, Neurological Sciences.

[28]  G. Plotnick,et al.  Patent foramen ovale: a review of associated conditions and the impact of physiological size. , 2001, Journal of the American College of Cardiology.

[29]  Q. Cao,et al.  Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: Feasibility and comparison with transesophageal echocardiography , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[30]  E. Zanette,et al.  Detection of Right-to-Left Shunt with Ultrasound Contrast Agent and Transcranial Doppler Sonography , 2000, Cerebrovascular Diseases.

[31]  T. Cheng.  Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study , 1999 .

[32]  W. Morrison,et al.  Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers , 1999, Heart.

[33]  B. McManus,et al.  Biological response to Bard Clamshell Septal Occluders in the canine heart. , 1996, Circulation.

[34]  R. Sacco,et al.  Patent Foramen Ovale as a Risk Factor for Cryptogenic Stroke , 1992, Annals of Internal Medicine.

[35]  J. Seward,et al.  Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. , 1985, Journal of the American College of Cardiology.

[36]  E. Rieber,et al.  Red cells in sickle cell crisis: observations on the pathophysiology of crisis. , 1977, Blood.

[37]  C. Younkin.  Multiphase MP35N alloy for medical implants. , 1974, Journal of biomedical materials research.